Vaccines for Pandemic Influenza
(Sprache: Englisch)
The recent outbreak of disease caused by a novel H1N1 virus has focused global attention on the threat of a new influenza pandemic. Recent years have also seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1...
Leider schon ausverkauft
versandkostenfrei
Buch
299.59 €
Produktdetails
Produktinformationen zu „Vaccines for Pandemic Influenza “
The recent outbreak of disease caused by a novel H1N1 virus has focused global attention on the threat of a new influenza pandemic. Recent years have also seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans resulting in numerous fatalities. The rapid expansion in the geographic distribution of these novel viruses raises the risk that such a virus could cause a global pandemic with high morbidity and mortality.
An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited antigenic relationships to the newly emerging virus strains.
Concerns about pandemic preparedness have greatly stimulated research activities to develop effective vaccines for pandemic influenza viruses, and to overcome the limitations inherent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine production; which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations... more on
http://springer.com/978-3-540-92164-6
An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited antigenic relationships to the newly emerging virus strains.
Concerns about pandemic preparedness have greatly stimulated research activities to develop effective vaccines for pandemic influenza viruses, and to overcome the limitations inherent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine production; which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations... more on
http://springer.com/978-3-540-92164-6
Klappentext zu „Vaccines for Pandemic Influenza “
Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated.
Inhaltsverzeichnis zu „Vaccines for Pandemic Influenza “
Preface.- Pandemic influenza as a current threat.- Designing vaccines for pandemic influenza.- Current vaccines for seasonal influenza.- Generation and characterization of candidate vaccine viruses for pre-pandemic influenza vaccines.- Recombinant proteins produced in insect cells.- Adjuvants for pandemic influenza vaccines.- Live attenuated vaccines for pandemic influenza.- Influenza vaccines for avian species.- Development and application of avian influenza vaccines in China.- Attenuated influenza virus vaccines with modified NS1 proteins.- DNA Vaccines against Influenza viruses.- Influenza neuraminidase as a vaccine antigen.- Recombinant vectors as influenza vaccines.- Universal Pandemic Influenza Vaccines.- Influenza virus-like particles as pandemic vaccines.- Antigenic cross-reactivity among H5N1 viruses.- Transcutaneous immunization with influenza vaccines.- Self-administered microneedle patches for pandemic influenza.- Animal models for evaluation of influenza vaccines.- Immunosenescence and influenza vaccine efficacy.- Summary of recent clinical trials.- Considerations for licensure of pandemic and pre-pandemic indications in the U.S..- Strategies for Broad Global Access to Pandemic Influenza Vaccines.- Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision-Making.- Subject index.
Bibliographische Angaben
- 2009, 532 Seiten, Maße: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben: Walter A. Orenstein, Richard W Compans
- Verlag: Springer Berlin Heidelberg
- ISBN-10: 3540921648
- ISBN-13: 9783540921646
- Erscheinungsdatum: 28.07.2009
Sprache:
Englisch
Kommentar zu "Vaccines for Pandemic Influenza"
0 Gebrauchte Artikel zu „Vaccines for Pandemic Influenza“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Vaccines for Pandemic Influenza".
Kommentar verfassen